Japanese Flu Drug ‘Effective’ Against Coronavirus In Clinical Trials, Chinese Officials Say

As the number of global coronavirus cases surpassed 200,000 as of Wednesday, a Japanese flu drug undergoing clinical trials in China as a possible treatment for coronavirus has effectively helped patients recover, Chinese officials told reporters according to multiple reports.

The drug, favipiravir, is sold under the brand name Avigan, and was developed by Fujifilm Toyama Chemical in 2014, according to Nikkei Asian Review.